Nina Fenouille

2.4k total citations
17 papers, 1.5k citations indexed

About

Nina Fenouille is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Nina Fenouille has authored 17 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Hematology. Recurrent topics in Nina Fenouille's work include Acute Myeloid Leukemia Research (4 papers), Bone and Dental Protein Studies (4 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Nina Fenouille is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Bone and Dental Protein Studies (4 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Nina Fenouille collaborates with scholars based in France, United States and Sweden. Nina Fenouille's co-authors include Alexandre Puissant, Patrick Auberger, Guillaume Robert, Frédéric Luciano, Sophie Raynaud, Sophie Tartare‐Deckert, Jill‐Patrice Cassuto, Marcel Deckert, Robert Ballotti and Stéphane Rocchi and has published in prestigious journals such as Nature Communications, Genes & Development and Blood.

In The Last Decade

Nina Fenouille

17 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nina Fenouille France 15 849 380 354 228 206 17 1.5k
Jorge A. Almenara United States 22 1.7k 1.9× 163 0.4× 454 1.3× 235 1.0× 243 1.2× 36 2.1k
Hee‐Jun Wee South Korea 22 887 1.0× 181 0.5× 354 1.0× 197 0.9× 87 0.4× 32 1.3k
Abdelhadi Rebbaa United States 21 1.0k 1.2× 134 0.4× 293 0.8× 228 1.0× 239 1.2× 46 1.6k
Miriam Erlacher Germany 23 1.6k 1.9× 206 0.5× 561 1.6× 266 1.2× 348 1.7× 78 2.5k
Xing Guo China 21 974 1.1× 175 0.5× 257 0.7× 250 1.1× 187 0.9× 61 1.4k
Lijun Di China 25 1.0k 1.2× 163 0.4× 602 1.7× 389 1.7× 92 0.4× 102 1.9k
Ricardo Sánchez‐Prieto Spain 26 1.3k 1.6× 154 0.4× 696 2.0× 374 1.6× 144 0.7× 74 2.1k
Janet Tien United States 12 875 1.0× 247 0.7× 294 0.8× 106 0.5× 266 1.3× 14 1.3k
Jiancheng Hu China 19 1.4k 1.6× 104 0.3× 390 1.1× 233 1.0× 219 1.1× 51 2.0k
Ralph K. Lindemann Germany 20 1.5k 1.7× 240 0.6× 421 1.2× 197 0.9× 175 0.8× 27 2.2k

Countries citing papers authored by Nina Fenouille

Since Specialization
Citations

This map shows the geographic impact of Nina Fenouille's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nina Fenouille with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nina Fenouille more than expected).

Fields of papers citing papers by Nina Fenouille

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nina Fenouille. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nina Fenouille. The network helps show where Nina Fenouille may publish in the future.

Co-authorship network of co-authors of Nina Fenouille

This figure shows the co-authorship network connecting the top 25 collaborators of Nina Fenouille. A scholar is included among the top collaborators of Nina Fenouille based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nina Fenouille. Nina Fenouille is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Fenouille, Nina, et al.. (2017). To be or not to be cell autonomous? Autophagy says both. Essays in Biochemistry. 61(6). 649–661. 10 indexed citations
2.
Tichet, Mélanie, Virginie Prod’homme, Nina Fenouille, et al.. (2015). Tumour-derived SPARC drives vascular permeability and extravasation through endothelial VCAM1 signalling to promote metastasis. Nature Communications. 6(1). 6993–6993. 157 indexed citations
3.
Meacham, Corbin E., Lee N. Lawton, Yadira M. Soto-Feliciano, et al.. (2015). A genome-scale in vivo loss-of-function screen identifies Phf6 as a lineage-specific regulator of leukemia cell growth. Genes & Development. 29(5). 483–488. 46 indexed citations
4.
Pikman, Yana, Alexandre Puissant, Gabriela Alexe, et al.. (2015). Targeting MTHFD2 in Acute Myeloid Leukemia. Blood. 126(23). 443–443. 1 indexed citations
5.
Puissant, Alexandre, Nina Fenouille, Gabriela Alexe, et al.. (2014). SYK Is a Critical Regulator of FLT3 in Acute Myeloid Leukemia. Cancer Cell. 25(2). 226–242. 109 indexed citations
6.
Puissant, Alexandre, Maeva Dufies, Nina Fenouille, et al.. (2012). Imatinib triggers mesenchymal-like conversion of CML cells associated with increased aggressiveness. Journal of Molecular Cell Biology. 4(4). 207–220. 32 indexed citations
7.
Fenouille, Nina, Mélanie Tichet, Maeva Dufies, et al.. (2012). The Epithelial-Mesenchymal Transition (EMT) Regulatory Factor SLUG (SNAI2) Is a Downstream Target of SPARC and AKT in Promoting Melanoma Cell Invasion. PLoS ONE. 7(7). e40378–e40378. 167 indexed citations
8.
Puissant, Alexandre, Nina Fenouille, & Patrick Auberger. (2012). When autophagy meets cancer through p62/SQSTM1.. PubMed. 2(4). 397–413. 219 indexed citations
9.
Fenouille, Nina, Alexandre Puissant, Mélanie Tichet, et al.. (2011). SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival. Oncogene. 30(49). 4887–4900. 53 indexed citations
10.
Fenouille, Nina, Sébastien Grosso, D. A. S. G. Mary, et al.. (2011). Calpain 2‐dependent IκBα degradation mediates CPT‐11 secondary resistance in colorectal cancer xenografts. The Journal of Pathology. 227(1). 118–129. 26 indexed citations
11.
Dufies, Maeva, Arnaud Jacquel, Guillaume Robert, et al.. (2011). Mechanism of action of the multikinase inhibitor Foretinib. Cell Cycle. 10(23). 4138–4148. 25 indexed citations
12.
Chéli, Yann, Sandy Giuliano, Nina Fenouille, et al.. (2011). Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells. Oncogene. 31(19). 2461–2470. 143 indexed citations
13.
Fenouille, Nina, Alexandre Puissant, Maeva Dufies, et al.. (2010). Persistent Activation of the Fyn/ERK Kinase Signaling Axis Mediates Imatinib Resistance in Chronic Myelogenous Leukemia Cells through Upregulation of Intracellular SPARC. Cancer Research. 70(23). 9659–9670. 52 indexed citations
14.
Puissant, Alexandre, Guillaume Robert, Nina Fenouille, et al.. (2010). Resveratrol Promotes Autophagic Cell Death in Chronic Myelogenous Leukemia Cells via JNK-Mediated p62/SQSTM1 Expression and AMPK Activation. Cancer Research. 70(3). 1042–1052. 323 indexed citations
15.
Fenouille, Nina, Guillaume Robert, Mélanie Tichet, et al.. (2010). The p53/p21Cip1/ Waf1 pathway mediates the effects of SPARC on melanoma cell cycle progression. Pigment Cell & Melanoma Research. 24(1). 219–232. 36 indexed citations
16.
Fenouille, Nina, Patricia Abbe, Guillaume Robert, et al.. (2009). Spleen Tyrosine Kinase Functions as a Tumor Suppressor in Melanoma Cells by Inducing Senescence-like Growth Arrest. Cancer Research. 69(7). 2748–2756. 66 indexed citations
17.
Lagadec, Patricia, Emmanuel Griessinger, Nina Fenouille, et al.. (2008). Pharmacological targeting of NF-κB potentiates the effect of the topoisomerase inhibitor CPT-11 on colon cancer cells. British Journal of Cancer. 98(2). 335–344. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026